| VariantVariant | GenotypeGenotype | Phenotype |
---|---|---|---|
β-thalassaemia | Normal | αα/αα | Normal |
 | Silent Carrier | -α/αα | Haematologically silent or mild reduction of MCH/MCV |
 | Minor | -α/-α , - -/αα | Borderline anaemia or normal, as well as microcytic and hypochromic red blood cells |
 | HbH disease* | - -/-α , - -/αTα, αTα/αTα T - -/- - T α T α | Majority have mild to moderate anaemia and marked microcytosis and hypochromia, only few have phenotype similar to thalassaemia major |
 | Barts Hydrops Foetalis | - -/- - | Most develop hydrops foetalis syndrome and die in utero, or shortly after birth |
β-thalassaemia | Normal | β/β | Normal |
 | Minor | β/β++ , β/β00 | Borderline anaemia or normal as well as microcytic and hypochromic red blood cells |
 | β-thalassaemia intermedia* | β + /β + ,β 0 /β + , β + /β, β 0 /β, β 0 /β 0 | Severity is very variable. Clinical picture ranges from mild to moderate NTDT |
 | Major | β0β0 , β0/β+ | Severe anaemia requiring regular transfusions (TDT) |
HbE | HbE trait | βE/β | Asymptomatic condition with no clinical relevance |
 | Homozygous HbE | βE/βE | Usually asymptomatic with borderline asymptomatic anaemia and no haemolysis |
 | HbE/ β-thalassaemia* | β E /β + ,β E /β 0 | Severity is very variable. Clinical picture ranges from NTDT to TDT |
 | HbE/HbS | βE/βS | Similar to sickle cell disease usually with rare vaso-occlusive crisis |